GEIGER COUNTER LIMITED Logo

GEIGER COUNTER LIMITED

GCL | IL

Overview

Corporate Details

ISIN(s):
GB00B15FW330 (+1 more)
LEI:
549300O6PWGLLYV1QX57
Country:
Jersey
Address:
Ordnance House, JE4 8PW St Helier
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genedrive PLC develops and commercializes easy-to-use, point-of-care pharmacogenetic tests for improved clinical outcomes. Our tests, such as the CYP2C19 ID Kit and MT-RNR1 ID Kit, are designed for rapid, time-critical settings.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for GEIGER COUNTER LIMITED. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-19 16:23
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-18 15:52
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-15 13:41
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-15 11:50
Transaction in Own Shares
Share Buyback
English 10.4 KB
2025-08-14 13:05
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-14 09:58
Transaction in Own Shares
Share Buyback
English 10.4 KB
2025-08-13 15:36
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-13 11:43
Transaction in Own Shares
Share Buyback
English 10.5 KB
2025-08-12 16:23
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-12 09:50
Transaction in Own Shares
Share Buyback
English 10.6 KB
2025-08-11 10:30
Transaction in Own Shares
Share Buyback
English 10.6 KB
2025-08-08 18:10
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-08 08:00
Post-Annual General Meeting Information
Results of General Meeting
English 15.4 KB
2025-08-07 16:04
Net Asset Value
Net Asset Value(s)
English 11.8 KB
2025-08-07 10:58
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 9.2 KB

Automate Your Workflow. Get a real-time feed of all GEIGER COUNTER LIMITED filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GEIGER COUNTER LIMITED via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
Vivoryon Therapeutics N.V. Logo
Develops small molecule therapies for severe age-related, inflammatory, and neurodegenerative diseases.
Germany VVY
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xintela AB Logo
Develops stem cell therapies and targeted antibody treatments for cancer and osteoarthritis.
Sweden XINT
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage therapeutics for autoimmune diseases.
Israel XTLB
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS
Zealand Pharma Logo
Develops innovative peptide medicines for metabolic and rare diseases.
Denmark ZEAL
Ziccum AB Logo
Licenses drying tech for thermostable vaccines & biologics, eliminating the cold chain.
Sweden ZICC